Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Link opens in a new tab
Search content at UTMB Health Research Expert Profiles
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Dysregulated biomarkers induce distinct pathways in preterm birth
L. Brou
, L. M. Almli
, B. D. Pearce
, G. Bhat
, C. O. Drobek
, S. Fortunato
,
R. Menon
Obstetrics & Gynecology
Research output
:
Contribution to journal
›
Article
›
peer-review
69
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Dysregulated biomarkers induce distinct pathways in preterm birth'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Dysregulated
100%
African American
100%
Preterm Birth
100%
European American
100%
Racial Disparities
50%
Fetal Plasma
50%
Biomarker Concentration
50%
Interleukin-1β
37%
Maternal-fetal
37%
MIP-1b
37%
Maternal Plasma
37%
MCP-3
37%
ANGPT2
37%
Intercellular Adhesion molecule-1 (ICAM-1)
25%
Plasma Biomarkers
25%
Eotaxin
25%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
25%
Interleukin-1 Receptor Antagonist (IL-1Ra)
25%
Amniotic Fluid
25%
Plasma Fluid
25%
Intra-amniotic
25%
Matrix Metalloproteinase 7 (MMP7)
25%
Inflammation
12%
Interleukin-10
12%
Spontaneous Preterm Birth (sPTB)
12%
Insulin-like Growth factor-1
12%
Interleukin-8
12%
Interleukin-6 Receptor (IL-6R)
12%
Pregnancy Outcome
12%
Platelet-derived Growth factor-BB (PDGF-BB)
12%
Biomarker Profile
12%
Preterm Birth Risk
12%
RANTES
12%
Nested Case-control Study
12%
IP-10
12%
Ingenuity Pathway Analysis
12%
Term Birth
12%
TGF-1
12%
Birth Control
12%
Tennessee
12%
Amniotic Fluid Samples
12%
Nashville
12%
Induced Preterm Birth
12%
Biomarker Analysis
12%
Protein Microarray
12%
Pathophysiological Pathways
12%
Perinatal Research
12%
Biochemistry, Genetics and Molecular Biology
Blood Plasma
100%
Tumor Necrosis Factor
50%
Interleukin-1
50%
Amnion Fluid
50%
ANGPT2
50%
Vascular Endothelial Growth Factor
33%
ICAM-1
33%
Eotaxin
33%
TIMP1
33%
Matrilysin
33%
Case-Control Study
16%
Interleukin 8
16%
Platelet-Derived Growth Factor
16%
Term Birth
16%
Protein Microarray
16%
Agricultural and Biological Sciences
Biological Marker
100%
Americans
72%
European Americans
72%
Blood Plasma
54%
Tumor Necrosis Factor
27%
Interleukin 1
27%
ICAM-1
18%
Vascular Endothelial Growth Factor
18%
Matrilysin
18%
Pregnancy Outcome
9%
Case-Control Study
9%
Interleukin 8
9%
Platelet-Derived Growth Factor
9%